Anti-signal recognition particle autoantibody ELISA validation and clinical associations

Objective. The aim of this study was to develop and validate a quantitative anti-signal recognition particle (SRP) autoantibody serum ELISA in patients with myositis and longitudinal association with myositis disease activity. Methods. We developed a serum ELISA using recombinant purified full-lengt...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Rheumatology (Oxford)
Auteurs principaux: Aggarwal, Rohit, Oddis, Chester V., Goudeau, Danielle, Fertig, Noreen, Metes, Ilinca, Stephens, Chad, Qi, Zengbiao, Koontz, Diane, Levesque, Marc C.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4473763/
https://ncbi.nlm.nih.gov/pubmed/25524922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keu436
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires